American Home Products Corp., Madison, NJ; Bristol-Myers Squibb Co., New York; Eli Lilly and Co., Indianapolis; Glaxo Wellcome Inc., Research Triangle Park, NC; Hoffman-La Roche Inc., Nutley, NJ; Merck & Co. Inc., Whitehouse Station, NJ; Novartis Pharmaceuticals Corp., East Hanover, NJ; Pfizer Inc., New York; Proctor & Gamble Co., Cincinnati; Schering-Plough Corp., Madison, NJ; SmithKline Beecham, Philadelphia; and Warner Lambert Co., Morris Plains, NJ were all named to Working Mother magazine's list of the "100 Best Companies for Working Mothers." Companies were rated on a scale of one to five (with five being the highest) in the following categories: childcare, flexibility, leave for new parents, work/life benefits and advancement of women. The list appeared in the October issue of the magazine.
American Home Products Corp., Madison, NJ; Bristol-Myers Squibb Co., New York; Eli Lilly and Co., Indianapolis; Glaxo Wellcome Inc., Research Triangle Park, NC; Hoffman-La Roche Inc., Nutley, NJ; Merck & Co. Inc., Whitehouse Station, NJ; Novartis Pharmaceuticals Corp., East Hanover, NJ; Pfizer Inc., New York; Proctor & Gamble Co., Cincinnati; Schering-Plough Corp., Madison, NJ; SmithKline Beecham, Philadelphia; and Warner Lambert Co., Morris Plains, NJ were all named to Working Mother magazine's list of the "100 Best Companies for Working Mothers." Companies were rated on a scale of one to five (with five being the highest) in the following categories: childcare, flexibility, leave for new parents, work/life benefits and advancement of women. The list appeared in the October issue of the magazine.
The companies named to the list voiced their support of additional employee benefits for working mothers. "I am pleased that SmithKline Beecham has been recognized as a leader in making employee support systems a top priority," said J.P. Garnier, chief executive officer of SmithKline Beecham. "We have worked diligently to incorporate this approach to doing business into our culture, all in an effort to help our employees maintain a balance between their work lives and personal lives."
Said John P. Ryan, senior vice president of human resources for Schering-Plough, "We believe our continued success is directly tied to the well-being of our diverse work force." PR
What Every Pharma CEO Should Know About Unlocking the Potential of Scientific Data
December 11th 2024When integrated into pharmaceutical enterprises, scientific data has the potential to drive organizational growth and innovation. Mikael Hagstroem, CEO at leading laboratory informatics provider LabVantage Solutions, discusses how technology partners add significant value to pharmaceutical R&D, in addition to manufacturing quality.
FDA Approves Hikma’s Generic GLP-1 Agonist for Type 2 Diabetes
December 24th 2024Approval marks the first generic version of liraglutide injection, referencing Victoza, for improving glycemic control in adults and children aged 10 years and older with type 2 diabetes, alongside diet and exercise.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.